P
Pyxis Oncology, Inc. (PYXS)
NMS – Real Time Price. Currency in USD
2.77
+0.54 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.77
+0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
2.77
+0.54 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.77
+0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Total debt $18.3M significantly exceeds cash reserves ($7.2M), raising financial stability concerns
Total current assets $45.6M exceed Total current liabilities $16.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.6) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$26.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.76 | 6.05 | 10 | |
| Quick ratio | 2.76 | 5.63 | 10 | |
| Debt to Equity | 0.58 | 0.30 | 7.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 16M | 14M | 14M |
| Gross Profit | -2M | -2M | 13M | 7M | 7M |
| Operating Income | -123M | -82M | -68M | -84M | -86M |
| Net Income | -121M | -74M | -77M | -80M | -82M |
| EBITDA | -122M | -80M | -66M | -80M | -81M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -99.11 | -17.5 | 1.0 |
| Next quarter | N/A | 18.21 | 5.0 |
| Current year | -99.64 | 2.83 | 2.5 |
| Next year | 8233.33 | -1.71 | 5.5 |
| Weighted average score | 3.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -28.52 | -32.13 | -149.34 | 1.0 |
| Y/Y | 999 | -9.98 | -5.7 | -15.37 | 3.3 |
| 3y average | 661.28 | 10.38 | 27 | 11.56 | 8.5 |
| 5y average | 796.37 | -103.99 | 35.06 | -68.45 | 5.5 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |